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Abstract
Background: Porcine Circovirus Type 2 (PCV2) is a pathogen that has the ability to cause often devastating disease
manifestations in pig populations with major economic implications. How PCV2 establishes subclinical persistence
and why certain individuals progress to lethal lymphoid depletion remain to be elucidated.
Results: Here we present PorSignDB, a gene signature database describing in vivo porcine tissue physiology
that we generated from a large compendium of in vivo transcriptional profiles and that we subsequently
leveraged for deciphering the distinct physiological states underlying PCV2-affected lymph nodes. This
systems genomics approach indicated that subclinical PCV2 infections suppress a myeloid leukocyte mediated
immune response. However, in contrast an inflammatory myeloid cell activation is promoted in PCV2 patients
with clinical manifestations. Functional genomics further uncovered STAT3 as a druggable PCV2 host factor
candidate. Moreover, IL-2 supplementation of primary lymphocytes enabled ex vivo study of PCV2 replication
in its target cell, the lymphoblast.
Conclusion: Our systematic dissection of the mechanistic basis of PCV2 reveals that subclinical and clinical PCV2 display
two diametrically opposed immunotranscriptomic recalibrations that represent distinct physiological states in vivo, which
suggests a paradigm shift in this field. Finally, our PorSignDB signature database is publicly available as a community
resource (http://www.vetvirology.ugent.be/PorSignDB/, included in Gene Sets from Community Contributors http://
software.broadinstitute.org/gsea/msigdb/contributed_genesets.jsp) and provides systems biologists with a valuable tool
for catalyzing studies of human and veterinary disease. Finally, a primary porcine lymphoblast cell culture system paves
the way for unraveling the impact of host genetics on PCV2 replication.
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Background
Porcine circovirus type 2 (PCV2) is a very small circular
single-stranded DNA virus that circulates endemically in
swine populations. Its limited coding capacity of approxi-
mately 1.7 kb only allows two major viral proteins: a capsid
protein (Cap), and a replication protein (Rep). An overlap-
ping viral protein, ORF3, was found to be implicated in
apoptosis, at least in vitro [1, 2]. PCV2 manifests itself
through a range of often devastating pathologies in swine
livestock, causing severe economic losses. The most prom-
inent disease associated with PCV2 is post-weaning multi-
systemic wasting syndrome (PMWS). PMWS patients
exhibit progressive weight-loss, respiratory distress, pallor
of skin, digestive disorders and sometimes jaundice, coin-
ciding with pneumonia, nephritis, hepatitis and severe
lymphadenopathy. Pathologic hallmarks in wasting pigs
include an elevated viral load, progressive lymphocytic
depletion and monocyte infiltration in lymph nodes [3],
which drastically compromises the immune system with
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often fatal outcome [4]. Although PCV2 is acknowledged
as the causative agent of PMWS, PCV2 infection alone
generally results in a persistent low-level replication
without clinical signs [5]. In fact, PCV2 circulates endemic-
ally in pig populations as covert subclinical infections,
seemingly undeterred by vaccination [6]. Pigs with PMWS
however, are nearly always presented with concurrent
microbial infections, which suggests a crucial role for
superinfections in triggering PMWS [7]. Indeed, coinfec-
tions or other immunostimulations such as adjuvant
administration were confirmed to produce PMWS in
experimental models [8]. In a real-life setting, piglets are
mostly affected after weaning. This presumably happens
because maternal antibodies cease to provide protection
[9]. Hence the name of the disease: PMWS.
Progress in PCV2 research is particularly hampered
by the lack of tools, reagents and resources that are
readily available for model species such as human or
mouse. In fact, most PCV2 studies are merely
descriptive and many important questions concerning
its pathology remain. It is widely accepted that PCV2
can establish an asymptomatic state with low-level
replication, but how PCV2 achieves such persistence
is unknown [10]. Furthermore, while many studies
have shown that superinfection can trigger PMWS,
mechanistic insight into why certain individuals trans-
form from subclinical PCV2 to PMWS remains
unknown. For these reasons, PCV2 pathology deserves
further investigation.
These days, large data sets measuring the transcriptomic
architecture of biological systems are increasingly available
in on-line repositories. They include those describing both
clinical and subclinical infections of PCV2-affected
lymphoid tissue [11, 12]. Specifically for the field of
porcine biology, many individual data sets from live
animals were only analyzed within the study for which
they were generated. As a consequence, integrated analysis
of the recent wealth of transcriptomic data opens oppor-
tunities for systems biologists. Here we take advantage of
large volumes of porcine transcriptomic studies to create
a novel gene signature collection of in vivo perturbation
signatures. We subsequently interrogated this database
against a circovirus patient study in order to better under-
stand lymph node host responses to PCV2 viral infections.
Results
PorSignDB: A gene set collection characterizing a
compendium of in vivo transcriptomic profiles
We first created PorSignDB, a collection of porcine gene
signatures, using a systematic approach previously devel-
oped for inference of the immunologic gene signature
collection ImmuneSigDB [13]. Specifically, we compiled
a large gene expression compendium curated from 65
studies including 1069 unique samples. A total of 256
annotated gene sets were derived from 128 pairwise
comparisons identifying genes induced and repressed in
one phenotype versus another, annotated as ‘UP’
(PHENOTYPE1_VS_PHENOTYPE2_UP) and ‘DOWN’
(PHENOTYPE1_VS_PHENOTYPE2_DN) gene sets, re-
spectively (Fig. 1a). To illustrate this, an example is given
for a study comparing lymph nodes of pigs experimen-
tally infected with Salmonella enterica Typhimurium
versus those of uninfected pigs [14]. Upregulated genes
(UP gene set) are highly expressed in the Salmonella-in-
fected phenotype, while downregulated genes (DN gene
set) are highly expressed in the uninfected phenotype
(Fig. 1b). Gene Ontology (GO) biological process gene
enrichment was performed for every gene set, and
provides an overview of the biological information
captured in this signature database (Additional file 1).
Gene set pairs where neither UP or DN yielded a single
significant GO term enrichment hit (Benjamini-Hoch-
berg corrected p-value < 0.05) were discarded in order to
retain only biologically meaningful gene sets.
This approach has a number of advantages over
ImmuneSigDB. First of all, ImmuneSigDB mainly covers
in vitro samples. For PorSignDB however, samples were
predominantly derived from real-life patients or labora-
tory animals (900 in vivo and 157 primary ex vivo speci-
mens out of a total of 1069). In consequence, it
constitutes a more natural description of the biological
processes going on in real-life situations. In addition,
while ImmuneSigDB only describes immune cell
transciptomics, the scope of PorSignDB is much wider
because its samples were derived from a multitude of
different tissues (Fig. 1c). Together, they describe host
responses in an entire range of biological themes, with a
major part stemming from studies on microbiology,
gastroenterology and the cardiovascular system (Fig. 1d).
Of note, porcine genes and individual probes were
mapped to Homo sapiens ortholog genes. Because many
transcriptional programs are evolutionarily conserved,
cross-species gene expression analysis can be applied suc-
cessfully [15, 16]. Moreover, molecular signature databases
are often human-oriented, and the porcine-to-human adap-
tation of PorSignDB thus facilitates its application to
genomic expression data of any species.
To demonstrate the validity of the information
contained in the PorSignDB gene sets, we examined a
study in which healthy human lungs were exposed to
either lipopolysaccharide (LPS) or saline infusion in vivo
[17]. In this particular study, alveolar macrophages were
obtained through bronchoalveolar lavage and their tran-
scriptomes mapped with microarray. We compared
transcriptomic profiles of LPS-exposed macrophages with
saline-solution exposed macrophages, and tested signa-
tures from PorSignDB for their enrichment (induced or
repressed) using Gene Set Enrichment Analysis (GSEA).
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Interestingly, PorSignDB also contains pairwise signatures
of LPS-stimulated macrophages VS unstimulated macro-
phages e.g. 2H_VS_0H_LPS_STIMULATION_BONE--
MORROW_DERIVED_MACROPHAGES. Indeed,
PorSignDB’s gene signatures of LPS-stimulated macro-
phages were highly induced (Fig. 1e, UP gene sets),
while the pairwise gene signatures of unstimulated
macrophages were repressed (Fig. 1e, DN gene sets).
This shows that PorSignDB signatures can be repro-
duced in comparable human datasets.
Next, we hypothesized that PorSignDB can be useful
because it can label samples with the tissue-specific
host-responses that they resemble. In this way, they may
provide new insight into genomic data. As an example,
we examined an RNA-seq dataset of a mouse myocardial
infarction model. In this study, interferon regulatory fac-
tor 3 (IRF3) knockout mice (IRF3−/−) showed improved
cardiac function and limited heart failure post myocar-
dial infarction [18]. When comparing the myocardial
transcriptomes of wild type (wt) with cardioprotective
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Fig. 1 Details of PorSignDB. a Overview of the pipeline. 88 curated studies with data from 1776 microarrays chips were retrieved from the GEO
repository. Data from each study was uniformly normalized using Genepattern, and gene expression signatures representing each phenotype of
every pairwise comparison were calculated in R. Systematical annotations were added to every signature, yielding 412 gene sets. PorSignDB logo
was made by NVR. b Example of signature generation. GSE7313 is a study mapping transcript abundance in mesenteric lymph nodes of pigs
infected with Salmonella Typhimurium at different time points. The first pair compares data from lymph nodes of uninfected pigs (Phenotype1)
with those of pigs 8 h post S. Typhimurium infection (Phenotype2). Significantly upregulated and downregulated genes were selected with a
mutual-information based metric, respectively recapitulating highly expressed genes in the ‘uninfected’ phenotype (UP gene set), and highly
expressed genes in the ‘8 h post S. Typhimurium infection’ phenotype (DN gene set). Clip art was made by NVR. c Samples were derived from a
variety of different tissues, d covering studies in a wide range of different biological themes. e Performance of PorSignDB LPS gene signatures in
alveolar macrophages of lungs treated with either LPS or saline solution. f Performance of PorSignDB myocardial infarction gene signatures in
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IRF3−/− knockout mice in GSEA, PorSignDBs myocar-
dial infarction tissue signatures were induced (Fig. 1f,
UP), while non-infarcted healthy control heart tissue
signatures were suppressed (Fig. 1f, DN). In other
words, wt myocardial tissue was labeled as ‘infarcted’,
while IRF3−/− knockout heart tissue was identified as
‘healthy control’, corroborating their respective pheno-
types. The PorSignDB myocardial infarction signatures
thus provide additional evidence of IRF3 as a driver of
heart failure in response to myocardial infarction. This
example demonstrates that PorSignDB can be applied
to any mRNA sequencing platform, and is therefore
not limited to the original Affymetrix porcine system
microarray from which the gene sets were derived.
Finally, the presence of multiple “viral” and “bacter-
ial” gene signatures in PorSignDB prompted the ques-
tion whether these signatures are heterogeneous, or
whether they represent a single similar “infection”
readout. In order to investigate this, we calculated
gene overlap between bacterial and viral gene signa-
tures (Additional file 2). This analysis shows that only
minor overlap exists. This argues that the majority of
viral and bacterial-related signatures represent unique
readouts of host responses. Similarly, the presence of
Salmonella Typhimurium and Salmonella Cholerae-
suis gene sets raised the question of to what extent
these molecular signatures share the same informa-
tion. However, gene overlap through hypergeometric
test did not yield any significant hit (Benjamini-Hoch-
berg corrected p-value < 0.05) (Additional file 3),
indicating that there is little redundancy between the
Salmonella Typhimurium and Choleraesuis gene sets.
The PorSignDB gene signatures are available as an online
resource (http://www.vetvirology.ugent.be/PorSignDB/;
Additional files 4 and 5) and can be used by systems biolo-
gists to deconvolute cellular circuitry in health and disease.
As proof of concept, we employed this gene signature collec-
tion describing host responses in a wide variety of tissues to
generate new insights in the multisystemic disease associated
with PCV2.
PorSignDB reveals diametrically opposed physiological
states in vivo in subclinical PCV2 and PMWS
We then leveraged PorSignDB to analyze a field study
of pigs naturally affected with PMWS [11]. To com-
pare transcriptomic profiles of PMWS lymph nodes
with PCV2-positive but otherwise healthy lymph
nodes, we tested signatures from PorSignDB for their
enrichment (induced or repressed) in both classes
using GSEA (Fig. 2a). We primarily focused on gene sets
pertaining to microbiology. For robustness, we only
retained signatures from pairwise comparisons in case both
upregulated (PHENOTYPE1_VS_PHENOTYPE2_UP) and
downregulated (PHENOTYPE1_VS_PHENOTYPE2_DN)
genes are significantly enriched (False discovery rate; FDR
< 0.01). For example, UP genes in splenic tissue of “Strepto-
coccus suis-infected pigs VS control pigs” are induced (Fig
2b, left heatmap first row), while DN genes are suppressed
(Fig. 2b, right heatmap first row).
Overall, this analysis reveals that upregulated genes in
“microbial challenge VS control” are induced while
downregulated genes are suppressed. In other words,
PMWS lymph nodes display transcriptomic reprogram-
ming consistent with tissue responses on infectious
agents. This observation is supported by previous find-
ings that naturally occurring PMWS is presented with
concurrent infections [7]. Strikingly, two genomic infec-
tion signatures do not follow this pattern. First, the op-
posite behavior of the gene signature from Salmonella
Typhimurium 21 days post inoculation (dpi) suggests
that the Salmonella infection has already been cleared at
this timepoint. This is indeed the case: at 21dpi the
bacterial load in these mesenteric lymph nodes was
reduced to undetectable levels [19]. In contrast, S. Cho-
leraesuis infection was sustained at 21dpi, coinciding
with persistent high bacterium abundance in mesenteric
lymph nodes. Intriguingly, the second deviating gene
signature originates from pigs that were subclinically in-
fected with PCV2 (Fig. 2a, arrow). Unlike S. Typhimur-
ium, this cannot be explained by pathogen clearance
since these experimentally PCV2-infected pigs remained
viremic throughout the original study [12]. Instead,
pathogen-distressed host responses appear here to be re-
pressed in lymph nodes with low-level subclinical PCV2
replication. Hence, highly expressed genes in “subclinical
PCV2-infected VS uninfected” lymph nodes are sup-
pressed, while lowly expressed genes are induced.
Finally, the gene sets PMWS_VS_HEALTHY_UP and
PMWS_VS_HEALTHY_DN serve as positive control
since they were derived from the data that was queried
in this instance. PorSignDB signatures from other
biological themes may provide additional clues into the
alterations in lymph nodes that are subject to PMWS
and could be explored further (Additional file 6, see also
discussion).
Interestingly, the GO analysis of PorSignDB gene sets re-
veals that the subclinical PCV2 infection signature 29 dpi
(UP) constitutes a transcriptional program implicated in cell
cycle progression (Additional file 1, gene set 33). On the
other hand, the uninfected pairwise signature (DN) summa-
rizes myeloid leukocyte activation implicated in the im-
mune response (Additional file 1, gene set 34). In other
words, this analysis suggests that upon PCV2 subclinical in-
fection, cell cycle progression is promoted, while myeloid
leukocyte immune responses are suppressed. To confirm
these findings, these gene sets were interrogated in lymph
nodes of pigs of the same study, but at other time points
[12]. Intriguingly, the onset of both the induction of UP
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(GO enrichment: “Cell cycle progression”) as the suppres-
sion of DN (GO: “Myeloid leukocyte activation”) was
immediate, robust, and persisted throughout all time points
(all FDRs < 0.001; Fig. 2c). It should be noted that the gene
signatures were derived from the 29 DPI time point, which
thus serves as a positive control. We recall from Fig. 2b that
this runs counter to PMWS patients, where UP is repressed
and DN is induced (both FDRs < 0.001).
From this data, it can be concluded that subclinical
PCV2 infection simulates pathogen-free tissue, upregulates
cell cycle regulator genes and represses myeloid leukocyte
activation genes implicated in the immune response. More-
over, these biological processes are reversed in PMWS
patients where cell cycle genes are suppressed and mye-
loid cell activation is induced.
A myeloid leukocyte mediated immune response
signature predicts clinical outcome of PCV2
In an experimental setting, PCV2 alone does not lead to
clinical signs. Additional superinfections or vaccination
challenges are needed to produce PMWS [8]. Why
extraneous immunostimulations trigger PMWS remains
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however poorly understood. A systems-level dissection
of PCV2-affected lymphoid tissue may provide an ex-
planation to this conundrum because it can determine
which transcripts characterize PMWS, unbiased by
previous knowledge. To this extent, the PMWS field
study data was divided over a training and validation co-
hort, and 173 biomarker genes were selected from the
training set using a leave-one-out cross validation
(Fig. 3a, Additional file 7). Together, they reveal a mo-
lecular portrait of PCV2-associated lymphoid lesions. This
‘PCV2 disease signature’ is greatly induced in the valid-
ation cohort as shown by GSEA analysis, meaning upregu-
lation of PMWS marker genes and downregulation of
Healthy marker genes (Fig. 3b). Interestingly, in medias-
tinal lymph nodes with subclinical PCV2 at 29dpi, the dis-
ease signature is dramatically repressed when compared
to lymph nodes of non-infected counterparts. This shows
once more that in subclinical PCV2 the transcrip-
tomic recalibration that goes hand in hand with
PMWS is suppressed. To illustrate the fidelity of the
PCV2 disease signature, individual samples were clas-
sified as either PMWS or healthy with the Nearest
Template Prediction algorithm [20]. All samples of
the validation set were correctly assigned (FDR < 0.05;
Fig. 3c). Furthermore, all piglets from the experimen-
tal study, either PCV2 free or with subclinical PCV2,
were correctly classified as Healthy. Only one sample
failed to meet the < 0.05 FDR threshold (Fig. 3d). Fur-
thermore, a Gene Ontology overrepresentation test in-
dicated that the PMWS biomarker genes represent
inflammatory responses and myeloid leukocyte
immune activation (Additional file 8, Figure A). Of
note, this gene signature performs better than an
RNMI-based signature (Additional file 8, Figure B-C),
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which is more suited for small sample sizes and was
therefore applied for generating PorSignDB.
Interestingly, when probing the kinetics of the
PCV2 disease signature in lymph nodes of pigs
experimentally infected with PCV2, S. Typhimurium
or S. Choleraesuis, it is clear that these two bacterial
infections promote the disease signature. In contrast,
in subclinical PCV2 it is consistently suppressed (Fig.
3e-g). In S. Typhimurium the reversal of this clinical
gene signature at 21 dpi coincides with the drop of
bacterial load in the mesenteric lymph nodes to
almost undetectable degree. This demonstrates from a
systems-approach that the infection has been virtually
cleared at this time point, unlike mesenteric lymph
nodes upon S. Choleraesuis infection. In the latter,
the persistence of the signature correlates with an
enduring high bacterial lymph node colonization [19].
Taken together, PCV2-induced lymphoid depletion
and granulomatous inflammation in PMWS patients
can be summarized in a robust gene expression signa-
ture emblematic of myeloid leukocyte activation. This
systems level analysis suggests that the initiation of a
myeloid leukocyte mediated immune response is a
pivotal event in the progression from subclinical
PCV2 to PMWS.
Functional genomics identify regulatory networks
perturbations in PCV2 disease
It is becoming increasingly clear that PMWS and sub-
clinical PCV2 represent two opposing adaptations of
lymphoid tissue to circoviral infection. To understand
how this tiny virus arranges this tour de force, the
data sets covering both the PMWS field study [11]
and the experimentally induced subclinical PCV2 at
29 dpi [12] were interrogated in the GSEA computa-
tional system with the innovative Hallmark gene set
collection [21]. This provides a very sensitive over-
view of alterations in a number of key regulatory
networks and signaling pathways in both PMWS
patients (Fig. 4a, leftmost column) and in pigs with
persistent subclinical PCV2 (Fig. 4, second column).
Since the molecular pathogenesis of PCV2 remains to
this day mostly unexplored [10, 22], this may uncover
several previously unknown network modifications [10, 22].
In lymphoid tissue of pigs with PMWS, many of the
affected transcriptional networks echo key events in
PCV2-associated lymphopathology such as blatant inflam-
matory activity (Hallmark gene set ‘Inflammatory response’)
and caspase-mediated cell death (‘Apoptosis’). Increases in
gene expression mediated by p53 (‘p53 pathways), reactive
oxygen species (‘ROS pathway’) and NF-κB (‘TNFα signal-
ing through NFκB’) reflect findings that PCV2 promotes
p53 expression [1, 2] and triggers NFκB activation through
ROS [23, 24] (Fig. 4, left column). Previously unidentified
altered networks [10, 22] include immunological programs
(‘Interferon alpha response’ and ‘Interferon gamma re-
sponse’), cell signaling cascades (‘IL2-STAT5 signaling’,
‘IL6-JAK-STAT3 signaling’, ‘KRAS signaling up’) and bio-
energetics (‘Glycolysis’ and ‘Hypoxia’).
Consistent with previous results, subclinical PCV2 in-
fection generally fails to reproduce the imbalances asso-
ciated with PMWS. Only the transcriptomic programs
downstream of interferon-α and interferon-γ are in line
with subclinical infections, suggesting a direct viral effect
on these immunological networks. It should also be noted
that the ‘Hallmark G2M checkpoint’, which describes a
transcriptional cell cycle program, is induced in subclinical
PCV2, and repressed in PMWS patients. This corrobo-
rates the earlier finding that genes implicated in cell cycle
progression are upregulated upon subclinical infection,
but downregulated in PMWS patients (Fig. 2c).
Most programs are however unaffected or opposed to
the changes occurring in PMWS, reaffirming the run-
ning thread that subclinical PCV2 and PMWS represent
two opposed transcriptomic recalibrations of lymph
node tissue.
IL-2 supplementation enables ex vivo modelling of PCV2
in primary porcine lymphoblasts
An increase in viral load in lymphoid tissue is a key
characteristic of PMWS [3]. In the PMWS field study,
PCV2 copy number was also significantly higher in the
PMWS lymph nodes compared to their healthy counter-
parts as measured by qPCR and in situ hybridization
[11]. The Hallmark analysis therefore shows that an in-
crease in the amount of PCV2 occurs in an environment
where IL-2 responsive genes are upregulated (Fig. 4a).
Given the pivotal role of IL-2 in activated T-cells during
immune response [25], IL-2 may indeed be a crucial fac-
tor in boosting subclinical PCV2 towards PMWS. Intri-
guingly, the IL2-STAT5 signaling network is suppressed
in subclinical PCV2, but not in S. Choleraesuis and S.
Typhimurium, where there is a persistent and transient
induction respectively (Fig. 5a). Again, in S. Typhimur-
ium, the reversal of the IL-2 signature coincides with
bacterial clearance.
The impact of IL-2 on PCV2 replication cannot be
faithfully demonstrated with traditional PK15 kidney
cells. Because PCV2 has a tropism for lymphoblasts,
these are the cells of choice. Our lab previously demon-
strated that treatment of freshly harvested PBMCs with
concanavalin A (ConA) coerces T-cells into mitosis, ren-
dering them permissive for PCV2 [26]. Unfortunately,
lymphoblast proliferation can only be maintained for a
very short time after which the cells forfeit viability and
die of attrition. Indeed, when isolated lymphocytes are
stimulated with ConA without IL-2, these cells start suf-
fering from apoptosis even before the first passage at
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72 h. However, supplementing ConA-stimulated lym-
phocytes with IL-2 generates continuously expanding
primary porcine lymphoblasts (PPLs; Fig. 5b, c). These
PPLs can be easily cultured, expanded and infected with
PCV2 ex vivo, providing a bona fide target cell culture
platform amenable for studying the PCV2 life cycle (Fig.
5d). To prove the beneficial effect of IL-2 on PCV2 rep-
lication, lymphocytes were freshly harvested from six in-
dividual pigs. IL-2 supplementation doubled PCV2
infection rates after 36 h, a timeframe amounting to a
single round of replication (Fig. 5e). PCV2 titers in 5 out
of 6 supernatants showed an increase upon IL-2 stimula-
tion. A more sensitive method, measuring PCV2 genome
copy numbers in cell culture supernatants showed a sig-
nificant increase upon IL-2 stimulation for all 6 lympho-
blast cell strains (Fig. 5f, g).
STAT3 is a PCV2 host factor and a target for antiviral
intervention
Since transcriptional networks of PMWS lymphoid tis-
sue are subject to dramatic changes that correlate with
fulminant PCV2 replication, counteracting these alter-
ations can potentially harm the viral life cycle. Given the
fierce induction of gene expression downstream the
IL6-JAK-STAT3 signaling cascade in PCV2 patients
(Additional file 9, Figure A), STAT3 emerges as a drug-
gable candidate host factor. Interestingly, STAT3 is a key
regulator of inflammation often exploited by viruses with
pathogenic consequences [27]. In a drug assay, treat-
ment with selective STAT3 inhibitor Cpd188 exhibits a
dose-dependent effect on PCV2 infection in PPLs at
72 hpi (Fig. 6a). Cell viability assay reveals no toxicity,
excluding non-specific adverse effects of the compound
on infection (Fig. 6b). Chemical inhibition also displays a
dose-dependent effect on PCV2 infection in PK15 cells
(Additional file 9, Figure B-D). Thus, robust expression
of STAT3 responsive genes are critical for PCV2, and
hampering STAT3 activity represents an antiviral strat-
egy (Fig. 6c).
A paracrine macrophage-lymphoblast communication
axis exacerbates PCV2 infection
Finally, the PMWS field study dataset (Fig. 2a) [11] was
queried in GSEA with ImmuneSigDB’s immunological
gene signatures [13]. At first glance, this approach may
seem incompatible as ImmuneSigDB describes single
types of immune cells, while the PMWS data set covers
complex lymph node tissues made out of multiple cells
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type. However, the main constituent of lymph nodes are
immune cells, which are particularly affected by PMWS.
It was therefore assumed that analyzing these data with
ImmuneSigDB could yield valuable information on the
biological processes going on inside these lymphoid
organs. Indeed, when comparing PMWS lymph nodes
with healthy lymph nodes in a GSEA analysis, it revealed
a striking suppression of lymphocyte gene expression
and powerful induction of signatures from monocytes
and other myeloid cells (Fig. 7a, Additional file 10). This
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reflects the loss of lymphocytes and histiocytic replace-
ment in PMWS lymph nodes. Together with the previ-
ous observation that a myeloid leukocyte activation
signature can predict clinical outcome of PCV2 (Fig. 3),
it raises the question to what extent infiltrating mono-
cytes affect PCV2 replication. After maturation into
macrophages, they may either dampen infection by
destroying viral particles, or promote PCV2 in a para-
crine fashion by releasing pro-inflammatory cytokines.
To test the effect of intercellular communication
between macrophages and lymphocytes, a co-culture
experiment was set up. PCV2-infected PPLs were
seeded in a porous insert, physically separated from a
lower compartment with primary porcine macro-
phages (Fig. 7b). The latter were challenged with
Porcine Reproductive and Respiratory Syndrome Virus
(PRRSV), a virus that can experimentally trigger
PMWS [8] (Fig. 7c).
The presence of non-infected macrophages had no sig-
nificant effect on PCV2 lymphoblast infection levels, but
when co-cultured with PRRSV-infected macrophages, a
significant and consistent increase in PCV2 infection could
be discerned (Fig. 7d). Importantly, PRRSV has an exclusive
tropism for macrophages [28, 29], and cannot infect
lymphoblasts (Additional file 11). This excludes an effect of
secondary infection of PRRSV on PCV2 replication in these
lymphoblasts. This experiment thus demonstrates the
existence of a previously unknown axis of intercellular
communication between macrophages and lymphoblasts
exacerbating PCV2 replication.
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Discussion
These days, online repositories provide an ever growing
library of transcriptomic data. In this study we unlock
the potential of porcine microarray studies by turning
them into an atlas of transcriptional host responses on
the tissue level. This approach extends MSigDB with in
vivo derived profiles [30]. A considerable part of the
PorSignDB gene set collection was only scantly
discussed (Additional file 12), but contains interesting
gene sets nonetheless. For example, the gene sets cover-
ing cystic fibrosis airway tissue may help in preclinical
drug discovery by examining whether a farmacological
intervention induces a ‘healthy’ signature. If in a par-
ticular transcriptomic analysis, the gene sets covering
“SSEA1-NEG_VS_SSEA1-POS_FETAL_FIBROBLASTS”
are overexpressed, it may indicate that SSEA1 (also
known as CD15 or FUT4) is implicated in the
biological process leading to the transcriptomic read-
out. Similarly, if gene sets describing resveratrol or
deoxynivalenol-supplemented tissues are induced, it
may indicate that these compounds can induce the
transcriptional reprogramming that was originally
queried. These are just a few hypothetical examples
that illustrate the potential of these gene sets for
generating hypotheses. In any case, their validity
remains to be confirmed by future studies.
PorSignDB is especially convenient for delineating
which physiological state one’s samples of interest
resemble, generating useful hypotheses in the process.
When applied to PCV2 patient data, PorSignDB shows
that lymph nodes of PMWS pigs resemble those from
pigs with microbial infections. At the same time, it
points out that subclinical PCV2 and PMWS are two
different host reactions to PCV2. It is important to
discriminate between these two phenotypes of ‘PCV2
infection’, because treating them as a single entity will only
result in conflicting data. As an example, this integrative
transcriptional analysis resolves the long-standing dichot-
omy in PMWS pathology of whether or not apoptosis is
implicated in lymphoid depletion in vivo [31–33]. In
lymphoid tissue with low-level replication, it is not. On
the other hand, in PMWS lymph nodes collapsing under
PCV2, genes mediating apoptosis are in full force (Fig. 4).
Another example of PorSignDB generating intriguing
hypotheses, is that weaned gut gene expression signatures
are induced in clinical PCV2, while intestinal signatures of
suckling piglets are suppressed (Additional file 4). This
echoes the clinical observation that pigs are most suscep-
tible to PMWS at time of weaning. It suggests that as long
as intestinal tissue is protected by maternal antibodies,
progression to PMWS is obstructed. On the other hand,
when weaned, naive intestinal tissue makes immuno-
logical contact with pathogens, producing a microenviron-
ment that reflects PMWS and hence, may promote PCV2.
When it comes to the PCV2 disease signature, caution
should be applied. It suggests that activation of myeloid
leukocytes, such as monocytes or macrophages, is a key
element distinguishing PMWS pigs from subclinically
infected pigs. However, for the generation of a valid
molecular signature, it is necessary that the training and
validation cohorts are similar. Even though these cohorts
are highly comparable on a clinical level (i.e. pathological
lesions such as viral load, degree of lymphoid depletion
and granulomatous inflammation [11], also indicated in
Additional file 9), no information is available on their
co-infection status. It is possible that this disease signa-
ture represents a specific co-infection that was circulat-
ing in swine farms at the time, and that the use of this
signature is therefore restricted to that particular
co-infection. Whether the PCV2 disease signature is
widely applicable thus remains to be confirmed in the
future by other cohorts.
Finally, the pronounced IL-2 signature in clinical PCV2
inspired the establishment of primary lymphoblast strains.
They can be easily expanded and stored in liquid nitrogen,
and display excellent post-thaw survival. Unlike PK-15 cells,
they can be harvested from different individuals or breeds,
providing a new and valuable tool for studying the
long-suspected impact of genetic background on PCV2
replication [34, 35]. However, a limitation of this cell
culture system is that it does not fully recapitulate PMWS
pathology. Upon IL-2 stimulation, cell death is prevented
and mitosis upregulated (Fig. 5b). In contrast, in PMWS,
cell cycle progression networks are downregulated (Fig. 2c,
Fig. 4). The latter seems contradictory as PCV2
genome replication highly depends on host cell poly-
merases, and hence, cells in mitosis [36]. This can be
explained by the fact that PMWS is an end-stage of
disease, where fulminant PCV2 replication has already
taken place, lymphoid parenchyma is overloaded with
PCV2 particles, and germinal centers have collapsed.
It also indicates that increasing the mitotic index is
not sufficient for generating the fulminant replication
leading to PMWS. Other factors are needed, and this
study suggests that the activation of myeloid
leukocyte mediated inflammatory host responses may
be another element of the puzzle. In any case,
whether the IL-2 cytokine itself is upregulated in
PMWS lymph nodes has never been demonstrated. It
is tempting to think that co-infections such as bacter-
ial or viral pathogens cause an infusion of IL-2 in the
lymph nodes, but this remains to be proved.
Conclusion
In conclusion, we here suggest a model to understand
how PCV2 establishes subclinical persistence, and how
it switches to clinical disease. Upon infection, PCV2
replicates at modest rates which seem unable to trigger a
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powerful immune response. This may cause lymphoid
tissue to act is if the pathogen is absent. Whenever an
individual falls victim to a stimulus that rewires the tran-
scriptional circuitry with a myeloid leukocyte mediated
immune activation, PCV2 replicates frantically and
overwhelms the host. Given its limited coding capacity,
PCV2 cannot manage it alone but depends on superin-
fections to recalibrate the host. This may help to explain
how PCV2 circulates in pig farms.
Materials and methods
Transcriptomic analysis
For transcriptomic studies, raw data were retrieved
from NCBI GEO (http://www.ncbi.nlm.nih.gov/geo/).
GEO accession numbers include GSE7313, GSE7314,
GSE8974, GSE12705, GSE13528, GSE14643, GSE1
4758, GSE14790, GSE15211, GSE15256, GSE15472,
GSE16348, GSE17264, GSE17492, GSE18343, GSE1
8359, GSE18467, GSE18641, GSE18854, GSE19083,
GSE19275, GSE19975, GSE21043, GSE21071, GSE2
1096, GSE21383, GSE21663, GSE22165, GSE22487,
GSE22596, GSE22782, GSE23503, GSE23596, GSE23
751, GSE24239, GSE24762, GSE24889, GSE26095,
GSE26663, GSE27000, GSE28003, GSE30874, GSE30
956, GSE31191, GSE32956, GSE33037, GSE33246,
GSE34569, GSE36306, GSE37166, GSE37922, GSE40
885, GSE41636, GSE43072, GSE44326, GSE47710,
GSE47814, GSE48125, GSE48839, GSE49290, GSE53
997, GSE64246, GSE65008, GSE66317, GSE72025,
GSE73088 and GSE106471. For microarray studies,
quantile normalized expression data was generated
from .CEL files using the ExpressionFileCreator
module on Genepattern [37]. Affymetrix porcine
genechip probe set identifiers were mapped to Homo
sapiens gene symbols as previously described [38]
with Refseq and Uniprot identifiers were changed
into corresponding gene symbols. For Affymetrix
HG-U133 plus 2, GSEA chip annotations were
employed. For RNA-seq, SRA files were converted to
Fastq files with Genepattern SraToFastQ module.
Reads were mapped to Mus musculus mm10 genome
assembly with Genepattern tophat module, and con-
verted to normalized to RPKM read counts using
cuffnorm on the galaxy public server [39]. GSEA ana-
lyses were performed with GSEA desktop v3.0 (http://
software.broadinstitute.org/gsea/index.jsp).
Generating PorSignDB
Affymetrix Porcine Genechip data available on NCBI
GEO were curated as follows. Data covering pooled
samples or lacking publication on Pubmed were
discarded, as were studies with < 2 samples per pheno-
type. Early transcriptional responses (< 30 mins) and
comparisons between breeds or tissue types were
ignored. If controls were unavailable for temporal
studies, comparisons were made with t = 0. For signature
generation, the ImmuneSigDB recipe [13] was followed.
Briefly, genes were correlated to a target profile and
ranked using the RNMI metric [40]. Top and bottom
ranked genes with an FDR < 0.01 in a permutation
test were included in two gene sets, with minimally
100 and maximally 200 genes each, yielding “PHENO-
TYPE1_VS_PHENOTYPE2_UP” and “PHENOTYPE1
_VS_PHENOTYPE2_DN”. To ensure informative gene
set comparisons, a GO biological process term enrichment
was performed for every gene set using clusterProfiler [41].
Comparisons where either UP or DN gene set yielded zero
significant hits (p < 0.05, Benjamini-Hochberg corrected)
were discarded.
PCV2 disease signature and phenotype classification
Biomarker genes were calculated from data of a field
study covering three different cohorts [11], according
to a previously described method [42] with minor
modifications. Cohorts were divided over a training
set (n = 17) and a validation set (n = 8). Marker genes
were ranked in the training set using signal-to-noise
ratio (S2NR), with standard deviations adjusted to
minimally 0.2*mean. In a subsequent leave-one-out
cross validation, a single sample was left out and a
permutation test was performed on the remaining
samples. Only genes with p < 0.05 in every iterative
leave-one-out trial were included in the signature. For
phenotype classification, the Nearest Template Predic-
tion (NTP) algorithm [20] was employed with S2NR
as weights.
Cells, virus and reagents
PCV1-negative PK15 (Porcine Kidney-15) cells were a kind
gift of Gordon Allan, Queen’s University, Belfast, UK. PK15
culture conditions were described earlier [43]. To generate
PPLs, PBMCs were isolated from whole blood collected
from hybrid Pietrain x Hypor Libra pigs by density centrifu-
gation as described previously [26]. After adhering of
monocytes to a plastic culture flask, lymphocytes in suspen-
sion were pelleted, resuspended in culture medium
supplemented with 5 μg/ml ConA (Sigma) and 50 μM
β-mercaptoethanol (Gibco). After three days, cells were pel-
leted, washed with RPMI (Gibco), and resuspended in
culture medium supplemented with 100 U/ml human
recombinant IL-2 (NIH) and 50 μM β-mercaptoethanol.
Porcine alveolar macrophages were isolated as described
[44]. PCV2 strains 1121 and Stoon1010 were described pre-
viously [45]. PRRSV Lelystad virus strain (LV) was
described earlier [44].
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Experimental infection and immunostaining
PK-15 and PPLs were inoculated with PCV2 1121 at 0.1
TCID50/cell for 1 h, washed and further incubated in
culture medium for 36 h. For Cpd188 experiments, cells
were pre-incubated for 1 h with Cpd188 (Merck Milli-
pore) dissolved in 0.25% DMSO. Subsequently, cells
were inoculated with PCV2 1121 at 0.1 TCID50/cell for
1 h, washed and incubated for 72 h. For co-culture, PPLs
and macrophages were inoculated at 0.5 TCID50/cell for
1 h with PCV2 Stoon1010 and PRRSV respectively,
washed and incubated for 72 h. PCV2 capsid immuno-
staining with monoclonal antibody (mAb) 38C1 was
described earlier [43].
For showing that PPLs are not susceptible to PRRSV,
Lymphoblasts were incubated with PRRSV LV strain at a
MOI of 0.5 or with media at 37C. After 1 h, the inocu-
lum/media was removed and cells were further cultured
for 72 h. Cells were stained with a mouse mAb 13E2
against nucleocapsid protein (produced in our lab, 1/50)
[46], followed by an FITC-conjugated goat-anti-mouse
IgG antibody (1/200; Invitrogen). Cell nuclei were coun-
terstained with Hoechst 33342 (1/100; Invitrogen). All
cell visualizations were performed with TCS SPE
confocal system (Leica Microsystems GmbH, Germany).
Alveolar macrophages were inoculated with PRRSV LV
strain and immunostained as a positive control.
Additional files
Additional file 1: GO biological process term enrichment of every gene
set in PorSignDB. (XLSX 662 kb)
Additional file 2: Overlap of bacterial and viral gene sets in PorSignDB.
(PDF 63 kb)
Additional file 3: Overlap of Salmonella Typhimurium and Salmonella
Choleraesuis gene sets in PorSignDB. (PDF 36 kb)
Additional file 4: PorSignDB signatures as HUGO gene symbols, in gmt
format. (GMT 344 kb)
Additional file 5: PorSignDB signatures as entrez symbols, in gmt
format. (GMT 305 kb)
Additional file 6: PorSignDB performance in lymph nodes of PMWS
pigs VS healthy pigs. Figure displays enriched PorSignDB gene sets in the
PMWS study pertaining to biological themes other than microbiology.
(PDF 92 kb)
Additional file 7: Complete list of PCV2 disease signature biomarker
genes. (XLSX 15 kb)
Additional file 8: PMWS biomarker genes annotation and performance
of an alternative clinical disease signature. A Gene ontology (GO) terms
overrepresentation test of PMWS biomarker genes. B Nearest Template
Prediction of test set samples using an alternative clincal gene signature
based on the RNMI metric C and similarly, of the experimental subclinical
infection samples at 29dpi. (ZIP 121 kb)
Additional file 9: STAT3 is a host factor in PCV2 disease. A Core genes
responsible for the STAT3 signature enrichment score. B STAT3-specific
inhibitor cpd-188 impairs infection in PK-15 cells. Means ± sd represents
three independent experiments in triplicate (n= 9; **P< 0.01, ***P< 0.001,
Mann-Whitney U-Test). C MTT cell viability assay of cpd-188 treatment in PK-15
cells. Means ± sd are shown for three independent experiments in quintuplicate
(n= 15). D Infection assessment by PCV2 capsid immunostaining, representative
figures for each treatment. Scale bar: 100 μm. (PDF 162 kb)
Additional file 10: ImmuneSigDB analysis of the PMWS field study
dataset. (XLSX 16 kb)
Additional file 11: PRRSV infection trial of primary porcine lymphoblasts.
(PDF 145 kb)
Additional file 12: PorSignDB annotation source file. (XLSX 25 kb)
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